Article Information
History
- May 31, 2018.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Donald M. Lyall, PhD1,
- Joey Ward, BSc1,
- Maciej Banach, MD PhD2,
- George Davey Smith, MD DSc3,4,
- Jason G. Gill, PhD5,
- Jill P. Pell, MD1,
- Michael V Holmes, MD PhD3,6,7,8,* and
- Naveed Sattar, MD PhD FMedSci5,*
- 1Institute of Health & Wellbeing, University of Glasgow, Scotland, UK
- 2Department of Hypertension, Medical University of Lodz, Poland
- 3Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, UK
- 4School of Social and Community Medicine, University of Bristol, Bristol, UK
- 5Institute of Cardiovascular and Medical Sciences, University of Glasgow, Scotland, UK
- 6Medical Research Council Population Health Research Unit at the University of Oxford, Oxford, UK
- 7Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, UK
- 8National Institute for Health Research, Oxford Biomedical Research Centre, Oxford University Hospital, Oxford, UK
- Correspondence to: Prof. Naveed Sattar, Institute of Cardiovascular and Medical Sciences, British Heart Foundation Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, G12 8TA, Email: Naveed.Sattar{at}glasgow.ac.uk, Tel: +44 141 330 3419 And Dr Michael Holmes, Medical Research Council Population Health Research Unit at the University of Oxford, Old Road Campus, Oxford, OX3 7LF, Email: Michael.Holmes{at}ndph.ox.ac.uk, Tel: +44 1865 74 3644
Posted May 31, 2018.
PCSK9 genetic variants, life-long lowering of LDL-cholesterol and cognition: a large-scale Mendelian randomization study
